Trident Texofab Statistics

Total Valuation

Trident Texofab has a market cap or net worth of INR 916.99 million. The enterprise value is 1.23 billion.

Market Cap	916.99M
Enterprise Value	1.23B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Trident Texofab has 15.00 million shares outstanding. The number of shares has decreased by -4.44% in one year.

Current Share Class	15.00M
Shares Outstanding	15.00M
Shares Change (YoY)	-4.44%
Shares Change (QoQ)	+1.11%
Owned by Insiders (%)	42.92%
Owned by Institutions (%)	0.88%
Float	8.38M

Valuation Ratios

The trailing PE ratio is 26.63.

PE Ratio	26.63
Forward PE	n/a
PS Ratio	0.75
PB Ratio	1.61
P/TBV Ratio	1.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	38.24
EV / Sales	1.01
EV / EBITDA	15.20
EV / EBIT	19.08
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.56
Debt / EBITDA	3.91
Debt / FCF	n/a
Interest Coverage	1.83

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	5.89%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	-1.46%
Revenue Per Employee	19.47M
Profits Per Employee	511,794
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Trident Texofab has paid 7.75 million in taxes.

Income Tax	7.75M
Effective Tax Rate	19.38%

Stock Price Statistics

The stock price has decreased by -61.71% in the last 52 weeks. The beta is -1.69, so Trident Texofab's price volatility has been lower than the market average.

Beta (5Y)	-1.69
52-Week Price Change	-61.71%
50-Day Moving Average	185.67
200-Day Moving Average	248.55
Relative Strength Index (RSI)	4.91
Average Volume (20 Days)	2,280

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Trident Texofab had revenue of INR 1.23 billion and earned 32.24 million in profits. Earnings per share was 2.30.

Revenue	1.23B
Gross Profit	176.68M
Operating Income	64.62M
Pretax Income	40.00M
Net Income	32.24M
EBITDA	79.77M
EBIT	64.62M
Earnings Per Share (EPS)	2.30

Full Income Statement

Balance Sheet

The company has 1.24 million in cash and 317.12 million in debt, with a net cash position of -315.88 million or -21.06 per share.

Cash & Cash Equivalents	1.24M
Total Debt	317.12M
Net Cash	-315.88M
Net Cash Per Share	-21.06
Equity (Book Value)	569.27M
Book Value Per Share	38.87
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 14.40%, with operating and profit margins of 5.27% and 2.63%.

Gross Margin	14.40%
Operating Margin	5.27%
Pretax Margin	3.26%
Profit Margin	2.63%
EBITDA Margin	6.50%
EBIT Margin	5.27%
FCF Margin	n/a

Dividends & Yields

Trident Texofab does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.44%
Shareholder Yield	4.44%
Earnings Yield	3.52%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 11, 2020. It was a forward split with a ratio of 2.4.

Last Split Date	Aug 11, 2020
Split Type	Forward
Split Ratio	2.4

Scores

Altman Z-Score	n/a
Piotroski F-Score	2